| Kathryn T Wilson, DO | |
|
3810 S Highway 27 Ste 1, Somerset, KY 42501-3073 | |
| (606) 678-4551 | |
| (606) 678-0972 |
| Full Name | Kathryn T Wilson |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 9 Years |
| Location | 3810 S Highway 27 Ste 1, Somerset, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851777825 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1996DT (Kentucky) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern Kentucky Eye Center, Psc | 4183701659 | 2 |
| Associates In Eye Care Inc | 7012908643 | 11 |
News Archive
Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, has announced positive results from a planned interim analysis of data collected six months after dosing from its ongoing Phase 2 dose optimization trial evaluating GEN-003 for the treatment of genital herpes. At its best performing dose of 60 µg per protein / 75 µg of Matrix-M2TM adjuvant, GEN-003 demonstrated a statistically significant 58 percent reduction from baseline in the viral shedding rate (p < 0.0001), the primary endpoint of the study.
Natural disasters such as Hurricane Harvey remind us that the health of a thriving population can become endangered in a matter of moments. With Hurricane Irma now expected to impact the east coast, disaster relief expert, William Blazey, D.O., reminds communities that peril continues in the aftermath of a catastrophe, as victims and responders are often unknowingly exposed to an array of short and long-term health risks.
Serological antibody immunoassays are one of the essential tools to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In a new study, Immunoglobulin G (IgG) antibodies are detected in a large cohort, lasting up to 140 days. The researchers propose an alternative to reverse transcription-polymerase chain reaction (RT-PCR) positive status as a standard for assessing SARS-CoV-2 antibody assays and show robust performance metrics for the AbC-19 rapid test.
Some privacy advocates say the government is seeking to move too quickly to digitize health records, and may risk exposing sensitive information to identity thieves and hackers. These privacy advocates appear to favor slow progress is spreading electronic records because - they hope - consumer safeguards can keep up with that pace.
› Verified 2 days ago
| Provider Name | Danville Eye Center, Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1619019213 PECOS PAC ID: 2365418878 Enrollment ID: O20040907000782 |
News Archive
Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, has announced positive results from a planned interim analysis of data collected six months after dosing from its ongoing Phase 2 dose optimization trial evaluating GEN-003 for the treatment of genital herpes. At its best performing dose of 60 µg per protein / 75 µg of Matrix-M2TM adjuvant, GEN-003 demonstrated a statistically significant 58 percent reduction from baseline in the viral shedding rate (p < 0.0001), the primary endpoint of the study.
Natural disasters such as Hurricane Harvey remind us that the health of a thriving population can become endangered in a matter of moments. With Hurricane Irma now expected to impact the east coast, disaster relief expert, William Blazey, D.O., reminds communities that peril continues in the aftermath of a catastrophe, as victims and responders are often unknowingly exposed to an array of short and long-term health risks.
Serological antibody immunoassays are one of the essential tools to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In a new study, Immunoglobulin G (IgG) antibodies are detected in a large cohort, lasting up to 140 days. The researchers propose an alternative to reverse transcription-polymerase chain reaction (RT-PCR) positive status as a standard for assessing SARS-CoV-2 antibody assays and show robust performance metrics for the AbC-19 rapid test.
Some privacy advocates say the government is seeking to move too quickly to digitize health records, and may risk exposing sensitive information to identity thieves and hackers. These privacy advocates appear to favor slow progress is spreading electronic records because - they hope - consumer safeguards can keep up with that pace.
› Verified 2 days ago
| Provider Name | Associates In Eye Care Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1649377177 PECOS PAC ID: 7012908643 Enrollment ID: O20050513000284 |
News Archive
Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, has announced positive results from a planned interim analysis of data collected six months after dosing from its ongoing Phase 2 dose optimization trial evaluating GEN-003 for the treatment of genital herpes. At its best performing dose of 60 µg per protein / 75 µg of Matrix-M2TM adjuvant, GEN-003 demonstrated a statistically significant 58 percent reduction from baseline in the viral shedding rate (p < 0.0001), the primary endpoint of the study.
Natural disasters such as Hurricane Harvey remind us that the health of a thriving population can become endangered in a matter of moments. With Hurricane Irma now expected to impact the east coast, disaster relief expert, William Blazey, D.O., reminds communities that peril continues in the aftermath of a catastrophe, as victims and responders are often unknowingly exposed to an array of short and long-term health risks.
Serological antibody immunoassays are one of the essential tools to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In a new study, Immunoglobulin G (IgG) antibodies are detected in a large cohort, lasting up to 140 days. The researchers propose an alternative to reverse transcription-polymerase chain reaction (RT-PCR) positive status as a standard for assessing SARS-CoV-2 antibody assays and show robust performance metrics for the AbC-19 rapid test.
Some privacy advocates say the government is seeking to move too quickly to digitize health records, and may risk exposing sensitive information to identity thieves and hackers. These privacy advocates appear to favor slow progress is spreading electronic records because - they hope - consumer safeguards can keep up with that pace.
› Verified 2 days ago
| Provider Name | Southern Kentucky Eye Center, Psc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1285776476 PECOS PAC ID: 4183701659 Enrollment ID: O20100421000480 |
News Archive
Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, has announced positive results from a planned interim analysis of data collected six months after dosing from its ongoing Phase 2 dose optimization trial evaluating GEN-003 for the treatment of genital herpes. At its best performing dose of 60 µg per protein / 75 µg of Matrix-M2TM adjuvant, GEN-003 demonstrated a statistically significant 58 percent reduction from baseline in the viral shedding rate (p < 0.0001), the primary endpoint of the study.
Natural disasters such as Hurricane Harvey remind us that the health of a thriving population can become endangered in a matter of moments. With Hurricane Irma now expected to impact the east coast, disaster relief expert, William Blazey, D.O., reminds communities that peril continues in the aftermath of a catastrophe, as victims and responders are often unknowingly exposed to an array of short and long-term health risks.
Serological antibody immunoassays are one of the essential tools to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In a new study, Immunoglobulin G (IgG) antibodies are detected in a large cohort, lasting up to 140 days. The researchers propose an alternative to reverse transcription-polymerase chain reaction (RT-PCR) positive status as a standard for assessing SARS-CoV-2 antibody assays and show robust performance metrics for the AbC-19 rapid test.
Some privacy advocates say the government is seeking to move too quickly to digitize health records, and may risk exposing sensitive information to identity thieves and hackers. These privacy advocates appear to favor slow progress is spreading electronic records because - they hope - consumer safeguards can keep up with that pace.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kathryn T Wilson, DO Po Box 306, Ferguson, KY 42533-0306 Ph: (606) 492-2211 | Kathryn T Wilson, DO 3810 S Highway 27 Ste 1, Somerset, KY 42501-3073 Ph: (606) 678-4551 |
News Archive
Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, has announced positive results from a planned interim analysis of data collected six months after dosing from its ongoing Phase 2 dose optimization trial evaluating GEN-003 for the treatment of genital herpes. At its best performing dose of 60 µg per protein / 75 µg of Matrix-M2TM adjuvant, GEN-003 demonstrated a statistically significant 58 percent reduction from baseline in the viral shedding rate (p < 0.0001), the primary endpoint of the study.
Natural disasters such as Hurricane Harvey remind us that the health of a thriving population can become endangered in a matter of moments. With Hurricane Irma now expected to impact the east coast, disaster relief expert, William Blazey, D.O., reminds communities that peril continues in the aftermath of a catastrophe, as victims and responders are often unknowingly exposed to an array of short and long-term health risks.
Serological antibody immunoassays are one of the essential tools to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In a new study, Immunoglobulin G (IgG) antibodies are detected in a large cohort, lasting up to 140 days. The researchers propose an alternative to reverse transcription-polymerase chain reaction (RT-PCR) positive status as a standard for assessing SARS-CoV-2 antibody assays and show robust performance metrics for the AbC-19 rapid test.
Some privacy advocates say the government is seeking to move too quickly to digitize health records, and may risk exposing sensitive information to identity thieves and hackers. These privacy advocates appear to favor slow progress is spreading electronic records because - they hope - consumer safeguards can keep up with that pace.
› Verified 2 days ago
Dr. Donald L Richardson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 246 Poplar Ave, Suite 1, Somerset, KY 42503 Phone: 606-679-5588 Fax: 606-677-9394 | |
Dr. Mark A Jacobs, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3810 S Highway 27, Suite 1, Somerset, KY 42501 Phone: 606-678-4551 Fax: 606-678-0972 | |
Timothy A Sparkman, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3810 S Highway 27 Ste 1, Somerset, KY 42501 Phone: 606-678-4551 Fax: 606-678-0972 | |
Harvey A. Schleter, OD PSC Optometrist Medicare: Accepting Medicare Assignments Practice Location: 709 E Mt Vernon St, Somerset, KY 42501 Phone: 606-679-5177 Fax: 606-678-9200 | |
Jennifer B. Compton, Od & Associates, Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 709 E Mount Vernon St Ste 1, Somerset, KY 42501 Phone: 859-494-0555 | |
Eye Health Specialists, Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 165 Parkers Mill Way, Somerset, KY 42503 Phone: 606-677-0377 Fax: 606-677-6542 | |
Southern Kentucky Eye Center Psc Optometrist Medicare: Medicare Enrolled Practice Location: 120 Tradepark Dr, Suite A, Somerset, KY 42503 Phone: 606-679-7778 Fax: 606-451-1814 |